Emerging biological roles for erythropoietin in the nervous system
The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Erythropoietin mediates an evolutionarily conserved, ancient immune response that limits damage to the heart, the nervous system and other tissues following injury. New evidence indicates that erythropoietin specifically prevents the destruction of viable tissue surrounding the site of an injury by signalling through a non-haematopoietic receptor. Engineered derivatives of erythropoietin that have a high affinity for this receptor have been developed, and these show robust tissue-protective effects in diverse preclinical models without stimulating erythropoiesis. A recent successful proof-of-concept clinical trial that used erythropoietin to treat human patients who had suffered a stroke encourages the evaluation of both this cytokine and non-erythropoietic derivatives as therapeutic agents to limit tissue injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2150]
Citations
Cites
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundSelf-citationHIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250 · cited 1×
“It is worrying that some cancer patients treated with rhEPO have also shown tumour expansio”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationJuhaszova, M., Zorov, D. B., Kim, S.-H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19906 · Cited by 1,026
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationIn vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundDigicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923 · cited 1×
“Furthermore, although it has been reported that STAT is part of erythropoietin's neuroprotective signalling cascade in vitro , in vivo studies largely have not supported the involvement of STATs in erythropoietin cytoprotectio”
BackgroundPurification of human erythropoietin.
Miyake, T., Kung, C. K., & Goldwasser, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63387-9 · Cited by 886
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Self-citation
Cited by
Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors
Katsimpardi, L., Litterman, N. K., Schein, P. A., Miller, C. M., Loffredo, F. S., Wojtkiewicz, G. R., Chen, J. W., Lee, R. T., Wagers, A. J., & Rubin, L. L. (2014) · Science · doi:10.1126/science.1251141 · Cited by 1,037
ERS clinical practice guidelines on treatment of sarcoidosis
Baughman, R. P., Valeyre, D., Korsten, P., Mathioudakis, A. G., Wuyts, W. A., Wells, A., Rottoli, P., Nunes, H., Lower, E. E., Judson, M. A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04079-2020 · Cited by 629
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.564872 · Cited by 605
Early management of severe traumatic brain injury
Rosenfeld, J. V., Maas, A. I., Bragge, P., Morganti-Kossmann, M. C., Manley, G. T., & Gruen, R. L. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60864-2 · Cited by 558
Metcalf, D. (2008) · Blood · doi:10.1182/blood-2007-03-079681 · Cited by 528
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Buffo, A., Rolando, C., & Ceruti, S. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.014 · Cited by 321
Anemia and Chronic Heart Failure
Anand, I. S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.044 · Cited by 314
Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
Brines, M., & Cerami, A. (2006) · Kidney International · doi:10.1038/sj.ki.5001546 · Cited by 290
Self-citationBrain micro-ecologies: neural stem cell niches in the adult mammalian brain
Riquelme, P. A., Drapeau, E., & Doetsch, F. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.2016 · Cited by 283
Zhong, W., Qian, K., Xiong, J., Ma, K., Wang, A., & Zou, Y. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.036 · Cited by 274
Erythropoietin deficiency decreases vascular stability in mice
Chen, J., Connor, K. M., Aderman, C. M., & Smith, L. E. H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33813 · Cited by 280
Pathologically activated therapeutics for neuroprotection
Lipton, S. A. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2229 · Cited by 257
Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001907 · Cited by 258
Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis
Ehrenreich, H., Fischer, B., Norra, C., Schellenberger, F., Stender, N., Stiefel, M., Sirén, A.-L., Paulus, W., Nave, K.-A., Gold, R., et al. (2007) · Brain · doi:10.1093/brain/awm203 · Cited by 236
Role of erythropoietin in the brain
Noguchi, C. T., Asavaritikrai, P., Teng, R., & Jia, Y. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.03.001 · Cited by 236
Zhang, J., Wu, Y., Jin, Y., Ji, F., Sinclair, S. H., Luo, Y., Xu, G., Lu, L., Dai, W., Yanoff, M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0721 · Cited by 226
Sirén, A.-L., Faßhauer, T., Bartels, C., & Ehrenreich, H. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.041 · Cited by 222
Westenbrink, B. D., Lipšic, E., van der Meer, P., van der Harst, P., Oeseburg, H., Du Marchie Sarvaas, G. J., Koster, J., Voors, A. A., van Veldhuisen, D. J., van Gilst, W. H., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm177 · Cited by 222
Nairz, M., Schroll, A., Moschen, A. R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Jamnig, C., Neurauter, D., Huber, L. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.002 · Cited by 194
“However, EPO also bears extrahematopoietic properties that are transduced by EPO receptors (EPORs) expressed on various nonerythroid tissues including immune cells (Brines and Cerami, 2005; Jelkmann, 2007).”
From oxygen to erythropoietin: Relevance of hypoxia for retinal development, health and disease
Caprara, C., & Grimm, C. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.11.003 · Cited by 176
Adaptive response of the heart to long-term anemia induced by iron deficiency
Naito, Y., Tsujino, T., Matsumoto, M., Sakoda, T., Ohyanagi, M., & Masuyama, T. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00463.2008 · Cited by 171
van der Kooij, M. A., Groenendaal, F., Kavelaars, A., Heijnen, C. J., & van Bel, F. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.04.007 · Cited by 163
Erythropoietin enhances hippocampal long-term potentiation and memory
Adamcio, B., Sargin, D., Stradomska, A., Medrihan, L., Gertler, C., Theis, F., Zhang, M., Müller, M., Hassouna, I., Hannke, K., et al. (2008) · BMC Biology · doi:10.1186/1741-7007-6-37 · Cited by 167
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin
Wakhloo, D., Scharkowski, F., Curto, Y., Javed Butt, U., Bansal, V., Steixner-Kumar, A. A., Wüstefeld, L., Rajput, A., Arinrad, S., Zillmann, M. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15041-1 · Cited by 163
Kellert, B. A., McPherson, R. J., & Juul, S. E. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e3180332cec · Cited by 158
The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease
Hasselblatt, M., Ehrenreich, H., & Sir??n, A.-L. (2006) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-200604000-00007 · Cited by 159
Villa, P., van Beek, J., Larsen, A. K., Gerwien, J. G., Christensen, S., Cerami, A., Brines, M. L., Leist, M., Ghezzi, P., & Torup, L. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600370 · Cited by 173
Self-citationSargin, D., Friedrichs, H., El-Kordi, A., & Ehrenreich, H. (2010) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2010.10.005 · Cited by 162
Gross, A. W., & Lodish, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510493200 · Cited by 155
Um, M., Gross, A. W., & Lodish, H. F. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.08.014 · Cited by 147
Erythropoietin: A Hormone with Multiple Functions
Lombardero, M., Kovács, K., & Scheithauer, B. W. (2011) · Pathobiology · doi:10.1159/000322975 · Cited by 151
Lee, S., Chu, K., Sinn, D., Jung, K., Kim, E., Kim, S., Kim, J., Ko, S., Kim, M., & Roh, J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03697.x · Cited by 139
Gorio, A., Madaschi, L., Stefano, A. B. D., Carelli, S., Giulio, A. M. D., Biasi, S. D., Coleman, T. R., Cerami, A., & Brines, M. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508479102 · Cited by 129
Self-citationInterventions for cognitive deficits in adults with brain tumours
Gehring, K., Sitskoorn, M. M., Aaronson, N. K., & TAPHOORN, M. J. B. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70111-x · Cited by 140
Coleman, T. R., Westenfelder, C., Tögel, F. E., Yang, Y., Hu, Z., Swenson, L., Leuvenink, H. G. D., Ploeg, R. J., d’Uscio, L. V., Katusic, Z. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601377103 · Cited by 127
Self-citationErythropoietin and Cancer: The Unintended Consequences of Anemia Correction
Debeljak, N., Solár, P., & Sytkowski, A. J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00563 · Cited by 133
The Not So ‘Mighty Chondrion’: Emergence of Renal Diseases due to Mitochondrial Dysfunction
Hall, A. M., & Unwin, R. J. (2006) · Nephron Physiology · doi:10.1159/000096860 · Cited by 131
Brain Protection by Erythropoietin: A Manifold Task
Rabie, T., & Marti, H. H. (2008) · Physiology · doi:10.1152/physiol.00016.2008 · Cited by 134
Plotnikov, E. Y., Chupyrkina, A. A., Jankauskas, S. S., Pevzner, I. B., Silachev, D. N., Skulachev, V. P., & Zorov, D. B. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.008 · Cited by 120
Pathophysiology of anemia and erythrocytosis
Hodges, V. M., Rainey, S., Lappin, T. R. J., & Maxwell, A. P. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.06.006 · Cited by 133
“[188] Brines M, Cerami A.”
BackgroundIshii, T., Asai, T., Oyama, D., Fukuta, T., Yasuda, N., Shimizu, K., Minamino, T., & Oku, N. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.004 · Cited by 116
Rey, F., Balsari, A., Giallongo, T., Ottolenghi, S., Giulio, A. M. D., Samaja, M., & Carelli, S. (2019) · ASN NEURO · doi:10.1177/1759091419871420 · Cited by 121
Erythropoietin mediated bone formation is regulated by mTOR signaling
Kim, J., Jung, Y., Sun, H., Joseph, J., Mishra, A., Shiozawa, Y., Wang, J., Krebsbach, P. H., & Taichman, R. S. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23347 · Cited by 114
Saito, F., Nakatani, T., Iwase, M., Maeda, Y., Hirakawa, A., Murao, Y., Suzuki, Y., Onodera, R., Fukushima, M., & Idé, C. (2008) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31815b847d · Cited by 113
Hassouna, I. A., Ott, C., Wüstefeld, L., Offen, N., Neher, R. A., Mitkovski, M., Winkler, D., Sperling, S., Fries, L., Goebbels, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.212 · Cited by 116
Savino, C., Pedotti, R., Baggi, F., Ubiali, F., Gallo, B. M., Nava, S., Bigini, P., Barbera, S., Fumagalli, E. R., Mennini, T., et al. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.10.016 · Cited by 112
“In addition to its hemopoietic effects, erythropoietin (EPO) possesses neuroprotective and neurotrophic properties (Brines and Cerami, 2005; Ghezzi and Brines, 2004; Jelkmann and Wagner, 2004; Juul, 2004).”
BackgroundSelf-citationGrowth factors in ischemic stroke
Lanfranconi, S., Locatelli, F., Corti, S. P., Candelise, L., Comi, G. P., Baron, P., Strazzer, S., Bresolin, N., & Bersano, A. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00987.x · Cited by 119
Nadam, J., Navarro, F. P., Sanchez, P. E., Moulin, C., Georges, B., Laglaine, A., Péquignot, J.-M., Morales, A., Ryvlin, P., & Bezin, L. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.009 · Cited by 110
“Exogenous administration of Epo revealed neuroprotective activity in vitro and in vivo in models of central and peripheral neuronal injury occurring in the contexts of trauma, stroke and inflammation (Juul et al., 2004; Campana and Myers, 2003; Maiese et al., 2004; Brines and Cerami, 2005).”
BackgroundCasals‐Pascual, C., Idro, R., Gicheru, N., Gwer, S., Kitsao, B. S., Gitau, E., Mwakesi, R., Roberts, D. J., & Newton, C. R. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709715105 · Cited by 112
Erythropoietin Enhances Hippocampal Response during Memory Retrieval in Humans
Miskowiak, K. W., O’Sullivan, U., & Harmer, C. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5013-06.2007 · Cited by 112
Um, M., & Lodish, H. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510943200 · Cited by 107
Aquaporin-4: A Potential Therapeutic Target for Cerebral Edema
Tang, G., & Yang, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101413 · Cited by 112
Bioactive cell-hydrogel microcapsules for cell-based drug delivery
Orive, G., Castro, M. D., Kong, H., Hernández, R. M., Márquez, S. P., Mooney, D. J., & Pedraz, J. L. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.01.005 · Cited by 115
Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons
Sanchez, P. E., Farès, R., Risso, J., Bonnet, C., Bouvard, S., Cavorsin, M. L., Georges, B., Moulin, C., Belmeguenaï, A., Bodennec, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901840106 · Cited by 102
Xiong, Y., Lu, D., Qu, C., Goussev, A. V., Schallert, T. J., Mahmood, A., & Chopp, M. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/109/9/0510 · Cited by 104
Erythropoietin: a multimodal neuroprotective agent
Byts, N., & Sirén, A. (2009) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-1-4 · Cited by 100
Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin
Byts, N., Samoylenko, A., Faßhauer, T., Ivanišević, M., Hennighausen, L. G., Ehrenreich, H., & Sirén, A. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.1 · Cited by 106
Erythropoietin as candidate for supportive treatment of severe COVID-19
Ehrenreich, H., Weißenborn, K., Begemann, M., Busch, M., Vieta, E., & Miskowiak, K. W. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00186-y · Cited by 100
“…expression is upregulated upon pathological conditions, e.g. brain injury of different etiologies, where it exerts anti-apoptotic, neuroprotective and neuroregenerative effects, independent of hematopoiesis (Brines and Cerami 2005; Digicaylioglu et al. 1995; Marti et al. 1996; Shingo et al. 2001).”
BackgroundErythropoietin modulation of astrocyte water permeability as a component of neuroprotection
Gunnarson, E., Song, Y., Kowalewski, J. M., Brismar, H., Brines, M. L., Cerami, A., Andersson, U., Zelenina, M., & Aperia, A. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812708106 · Cited by 107
Self-citationNovel interventions to reduce oxidative-stress related brain injury in neonatal asphyxia
Solevåg, A. L., Schmölzer, G. M., & Cheung, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.028 · Cited by 105
Alternative Erythropoietin Receptors in the Nervous System
Ostrowski, D., & Heinrich, R. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020024 · Cited by 100
Functional and molecular interactions between aquaporins and Na,K-ATPase
Illarionova, N. B., Gunnarson, E., Li, Y., Brismar, H., Bondar, A. A., Zelenin, S. M., & Aperia, A. C. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.062 · Cited by 102
Erythropoietin for infants with hypoxic–ischemic encephalopathy
McPherson, R. J., & Juul, S. E. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328336eb57 · Cited by 95
Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin
Sirén, A., Radyushkin, K., Boretius, S., Kämmer, D., Riechers, C.-C., Natt, O., Sargin, D., Watanabe, T., Sperling, S., Michaelis, T., et al. (2005) · Brain · doi:10.1093/brain/awh703 · Cited by 102
Mengozzi, M., Cervellini, I., Villa, P., Erbayraktar, Z., Gökmen, N., Yılmaz, O., Erbayraktar, S., Manohasandra, M., Hummelen, P. V., Vandenabeele, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200554109 · Cited by 97
Widespread Expression of Erythropoietin Receptor in Brain and Its Induction by Injury
Ott, C., Martens, H., Hassouna, I. A., Oliveira, B., Erck, C., Zafeiriou, M.-P., Peteri, U., Hesse, D., Gerhart, S., Altas, B., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00192 · Cited by 95
Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia
Wüstenberg, T., Begemann, M., Bartels, C., Gefeller, O., Stawicki, S., Hinze‐Selch, D., Mohr, A., Falkai, P., Aldenhoff, J., Knauth, M., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.51 · Cited by 93
Erythropoietin Protects from Post-Traumatic Edema in the Rat Brain
Verdonck, O., Lahrech, H., Francony, G., Carle, O., Farion, R., van de Looij, Y., Rémy, C., Segebarth, C. M., & Payen, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600443 · Cited by 96
Jang, W., Kim, H., Li, H., Jo, K. D., Lee, M. K., & Yang, H. O. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9316-x · Cited by 92
Erythropoietin reduces epileptogenic processes following status epilepticus
Chu, K., Jung, K., Lee, S., Kim, J., Kang, K., Lim, J., Lim, J., Park, H.-K., Kim, M., Lee, S. K., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01644.x · Cited by 88
Hojman, P., Brolin, C., Gissel, H., Brandt, C., Zerahn, B., Pedersen, B. K., & Gehl, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005894 · Cited by 87
King, V. R., Averill, S., Hewazy, D., Priestley, J. V., Torup, L., & Michael-Titus, A. T. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05635.x · Cited by 88
Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
Shirani, A., Okuda, D. T., & Stüve, O. (2016) · Neurotherapeutics · doi:10.1007/s13311-015-0409-z · Cited by 93
Brines, M. L. (2010) · Blood Purification · doi:10.1159/000245630 · Cited by 86
Self-citationLuo, B., Wang, J., Liu, Z., Shen, Z., Shi, R., Liu, Y., Liu, Y., Jiang, M., Wu, Y., & Zhang, Z. (2016) · Nature Communications · doi:10.1038/ncomms12177 · Cited by 85
Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword?
Velly, L. J., Pellegrini, L., Guillet, B. A., Bruder, N. J., & Pisano, P. S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.002 · Cited by 82
“In the same way, the binding affinities of rhEPO for EPOR expressed by non-erythroid cells are much lower than the concentration of circulating EPO in human serum, even in patients with anemia (Brines & Cerami, 2005).”
BackgroundMolecular mechanisms of ischemic preconditioning in the kidney
Kapitsinou, P. P., & Haase, V. H. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2015 · Cited by 81
Erythropoietin and renoprotection
Bahlmann, F. H., & Fliser, D. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32831a9dde · Cited by 80
Bennis, Y., Sarlon-Bartoli, G., Guillet, B. A., Hubert, L., Pellegrini, L., Velly, L. J., Blot‐Chabaud, M., Dignat‐George, F., Sabatier, F., & Pisano, P. S. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04835.x · Cited by 79
Miskowiak, K. W., Inkster, B., Selvaraj, S., Wise, R. G., Goodwin, G. M., & Harmer, C. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301439 · Cited by 82
Leconte, C., Bihel, E., Lepelletier, F.-X., Bouët, V., Saulnier, R., Petit, E., Boulouard, M., Bernaudin, M., & Schumann‐Bard, P. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.025 · Cited by 84
Montero, M., Poulsen, F. R., Noraberg, J., Kirkeby, A., van Beek, J., Leist, M., & Zimmer, J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.09.026 · Cited by 80
Girgenti, M. J., Hunsberger, J. G., Duman, C. H., Sathyanesan, M., Terwilliger, R. Z., & Newton, S. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.12.005 · Cited by 83
Coldewey, S. M., Khan, A. I., Kapoor, A., Collino, M., Rogazzo, M., Brines, M. L., Cerami, A., Hall, P. A., Sheaff, M. T., Kieswich, J. E., et al. (2013) · Kidney International · doi:10.1038/ki.2013.118 · Cited by 78
Self-citationEhrenreich, H., Kästner, A., Weißenborn, K., Streeter, J., Sperling, S., Wang, K., Worthmann, H., Hayes, R. L., von Ahsen, N., Kastrup, A., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00259 · Cited by 78
Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice
Ueda, K., Takano, H., Niitsuma, Y., Hasegawa, H., Uchiyama, R., Oka, T., Miyazaki, M., Nakaya, H., & Komuro, I. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39896 · Cited by 82
Neuronal Control of Breathing: Sex and Stress Hormones
Behan, M., & Kinkead, R. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100027 · Cited by 81
Review of recent studies on interventions for cognitive deficits in patients with cancer
Gehring, K., Roukema, J. A., & Sitskoorn, M. M. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.202 · Cited by 78
Understanding ischemic retinopathies: emerging concepts from oxygen-induced retinopathy
Kermorvant‐Duchemin, E., Sapieha, P. S., Sirinyan, M., Beauchamp, M., Checchin, D., Hardy, P., Sennlaub, F., Lachapelle, P., & Chemtob, S. (2009) · Documenta Ophthalmologica · doi:10.1007/s10633-009-9201-x · Cited by 73
“The pro-angiogenic effects of EPO were found to be independent of VEGF [28, 30] but mediated through both modulation of the pro-survival factor NFj Bb y EPO receptor activation [ 27 , 28] and systemic recruitment of pro-angiogenic stem cells in the retina [28].”
BackgroundErythropoietin in spinal cord injury
Matis, G., & Birbilis, T. A. (2008) · European Spine Journal · doi:10.1007/s00586-008-0829-0 · Cited by 73
Sargin, D., El-Kordi, A., Agarwal, A., Müller, M., Wojcik, S. M., Hassouna, I., Sperling, S., Nave, K., & Ehrenreich, H. (2011) · BMC Biology · doi:10.1186/1741-7007-9-27 · Cited by 71
Fuentealba, J., Hernandez, C., Burgos, C. F., Hidalgo-Gajardo, A., Silva-Grecchi, T., Gavilán, J., & Toledo, J. R. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.215240 · Cited by 79
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
Miskowiak, K. W., Vinberg, M., Harmer, C. J., Ehrenreich, H., & Kessing, L. V. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2511-1 · Cited by 78
Sanchez, P. E., Navarro, F. P., Farès, R., Nadam, J., Georges, B., Moulin, C., Cavorsin, M. L., Bonnet, C., Ryvlin, P., Belmeguenaï, A., et al. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22020 · Cited by 70
Cardiac Molecular-Acclimation Mechanisms in Response to Swimming-Induced Exercise in Atlantic Salmon
Castro, V., Grisdale‐Helland, B., Helland, S. J., Torgersen, J. S., Kristensen, T., Claireaux, G., Farrell, A. P., & Takle, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055056 · Cited by 77
Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial
Mariotti, C., Fancellu, R., Caldarazzo, S., Nanetti, L., Bella, D. D., Plumari, M., Lauria, G., Cappellini, M. D., Duca, L., Solari, A., et al. (2012) · Movement Disorders · doi:10.1002/mds.24066 · Cited by 68
Neuroprotective role of erythropoietin by antiapoptosis in the retina
Chung, H., Lee, H.-J., Lamoke, F., Hrushesky, W. J. M., Wood, P. A., & Jahng, W. J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22046 · Cited by 68
Basile, L. A., Ellefson, D., Gluzman-Poltorak, Z., Junes-Gill, K., Mar, V., Mendonca, S., Miller, J. D., Tom, J., Trinh, A., & Gallaher, T. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030434 · Cited by 64
Durussel, J., Daskalaki, E., Anderson, M., Chatterji, T., Wondimu, D. H., Padmanabhan, N., Patel, R. K., McClure, J. D., & Pitsiladis, Y. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056151 · Cited by 62
Metadata
- Authors
- Brines, M., & Cerami, A.
- Corresponding author
- Brines, Michael
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-06-01
- Volume
- 6
- Issue
- 6
- Pages
- 484-494
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2168867226
- Cited by
- 523
- References
- 108
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 18 · 2021: 21 · 2020: 13 · 2019: 25 · 2018: 17 · 2017: 16 · 2016: 21 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 38
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Update notices
- correction (2005-08-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- www.springer.com/tdm (unspecified)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- erythropoietin, nervous system, neuroprotection, tissue damage, stroke, neuroinflammation
- MeSH terms
- Animals, Central Nervous System, Erythropoietin, Humans, Signal Transduction, Receptors, Cytokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.